Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Shehata, Miral Magdya | Sallam, Al-Aliaa Mohameda; b | Naguib, Mary Gamalc | EL-Mesallamy, Hala Osmana; d; *
Affiliations: [a] Biochemistry Department, Faculty of Pharmacy, Ain Shams University (ASU), Abassia, Cairo, Egypt | [b] Biochemistry Department, School of Pharmacy and Pharmaceutical Industries, Badr University in Cairo (BUC), Badr City, Cairo, Egypt | [c] Hematology Department, Faculty of Medicine, Ain Shams University (ASU), Cairo, Egypt | [d] Biochemistry Department, Dean of Faculty of Pharmacy, Sinai University (SU), Sinai, Egypt
Correspondence: [*] Corresponding author: Hala Osman EL-Mesallamy, Professor of Biochemistry, Ain Shams University, Dean of Faculty of Pharmacy, Sinai University, Sinai, 71526, Egypt. Tel.: +20 2245051107/+20 1061669913; Fax: +20 2245051107; E-mail: hala_elmosalamy@hotmail.com.
Abstract: BACKGROUND: Bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) and mothers against decapentaplegic homolog 7 (SMAD7) are important transforming growth factor-β (TGF-β) signaling antagonists, however their roles in acute myeloid leukemia (AML) remains unclear. Telomerase reverse transcriptase (TERT) may be involved in regulating BAMBI and SMAD7 expressions; a role beyond telomeres that is not clinically validated yet. OBJECTIVE: In this study, we examined the expression levels and prognostic values of BAMBI, SMAD7 and TERT and their association with AML patients’ outcomes. METHODS: Blood samples were collected from 74 de-novo AML patients and 16 controls. Real-time quantitative PCR (qRT-PCR) was performed to analyze BAMBI, SMAD7 and TERT expressions. RESULTS: BAMBI and SMAD7 expression in AML were significantly upregulated versus controls (p< 0.05). BAMBI, SMAD7 and TERT levels were significantly correlated together (p< 0.001). Kaplan-Meier analysis indicated that patients with high BAMBI, SMAD7 and TERT expression levels had markedly shorter event free survival (EFS) and overall survival (OS) time (p< 0.01). Furthermore, multivariate analysis revealed that only high BAMBI expression was an independent risk factor for OS (p= 0.001). CONCLUSIONS: BAMBI is a novel biomarker in predicting prognosis in AML patients. Moreover, a potential interplay is found between BAMBI, SMAD7 and TERT in AML pathogenies.
Keywords: Acute myeloid leukemia, transforming growth factor-β, BAMBI, SMAD7, TERT
DOI: 10.3233/CBM-200927
Journal: Cancer Biomarkers, vol. 31, no. 1, pp. 47-58, 2021
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl